Back to Search
Start Over
Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma.
- Source :
-
Frontiers in immunology [Front Immunol] 2022 Dec 15; Vol. 13, pp. 1079253. Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Advanced endometrial clear cell carcinoma (CCC) tends to have poor prognosis owing to aggressive clinical behavior and poor response to conventional chemotherapy. Herein, we report a case of platinum-refractory recurrent ECCC successfully treated with the combination of pembrolizumab, localized radiotherapy and a few cycles of chemotherapy with an extremely durable response even after cessation of immunotherapy for 3 years at the time of publication.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Kao, Liu, Lin, Huang, Lan, Ou, Fu and Wu.)
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Report
- Accession number :
- 36591227
- Full Text :
- https://doi.org/10.3389/fimmu.2022.1079253